Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.210
-0.150 (-6.36%)
At close: Dec 18, 2025, 4:00 PM EST
2.200
-0.010 (-0.45%)
After-hours: Dec 18, 2025, 7:55 PM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $90.8 million as of December 18, 2025. Its market cap has increased by 125.88% in one year.
Market Cap
90.80M
Enterprise Value
78.80M
1-Year Change
125.88%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $90.80M, a decrease of -44.25%. That is a compound annual growth rate of -11.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 90.80M | 108.40% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
| May 7, 2021 | 162.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.07B |
| Johnson & Johnson | 506.39B |
| AbbVie | 398.33B |
| UnitedHealth Group | 298.65B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 248.65B |
| Abbott Laboratories | 220.26B |